The retinoid-derivative ingredients, which can be combined with a secondary ingredient for further efficacy or improved effectiveness, are a novel option for manufacturers looking to avoid the potential unwanted secondary effects of traditional retinoids.
Conagen is a Massachusetts-based biotechnology company that develops synthetic biology solutions for food, pharmaceutical, and renewable materials industries.